Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Opiate Withdrawal Syndrome in Norway
Total 0 results
Nothing found
Sponsors and Collaborators
iCAD
Neurophth Therapeutics Inc
Eurofins Genoma
ASST Cremona, Cremona
Kupfer, David J., M.D.
RMIT University, Melbourne, Australia
Hospital ASEPEYO Sant Cugat
Agency for Science, Technology and Research
Alma Lasers Inc.
Mª Victoria Maestre Sanchez
Nacuity Pharmaceuticals, Inc.
Everett Meyer
GFI
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Korean Society of Spine Surgery
Hospital Durand, Argentina
Apollo Neuroscience, Inc.
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Aptis Medical
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
View Full List
Medical Conditions
Recurrent Clear Cell Sarcoma of Soft Tissue
Dienogest
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Corneal Cross-Linking
Immune-Mediated Inflammatory Disease
Splenic Trauma
Major Liver Surgery
Treatment Decisions
Gastric Cancer Stage IIIB-IIIC
T-LGL Leukemia
Chronic Constipation Symptoms
Scleredema
The Strength Properties of the Aorta in Vitro
Luteal Phase Support
Fever
Rheumatoid Arthritis(RA)
RISS Stage III Plasma Cell Myeloma
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Metachronous Adenoma
Disorder of Fluid Balance
View Full List
Drug Interventions
THC
Letrozole
GLPG1837 multiple ascending doses
Olopatadine
Oxycodone/acetaminophen 5/325 mg
Standard of care (SOC) for COVID-19
Intravenous Formulation of PD-0332991
Capecitabine and IMRT (if randomized to this arm)
Fospropofol disodium, propofol
RDX227675
Intravenous deferiprone
Anticholinergic
Midazolam
TPN-101
MLN2480
OnabotulinumtoxinA
Camptosar
Desvenlafaxine
PD-1/PD-L1 inhibitor
Capecitabine/cisplatin
View Full List
CROs by country
Contract Research Organizations in Burundi
Contract Research Organizations in Canada
Contract Research Organizations in Czech Republic
Contract Research Organizations in Djibouti
Contract Research Organizations in Guinea
Contract Research Organizations in Hungary
Contract Research Organizations in Indonesia
Contract Research Organizations in Jamaica
Contract Research Organizations in Kuwait
Contract Research Organizations in Romania
Contract Research Organizations in Russia
Contract Research Organizations in South Africa
Contract Research Organizations in Thailand
CRO list by country
CROs in Djibouti
SGS
All CROs in Djibouti
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe